ZimVie (NASDAQ:ZIMV) Posts Earnings Results

ZimVie (NASDAQ:ZIMV) released its quarterly earnings results on Wednesday. The company reported $0.08 earnings per share for the quarter, Zacks reports. The company had revenue of $118.20 million for the quarter. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%. During the same period last year, the firm posted $0.25 EPS. ZimVie updated its FY 2024 guidance to 0.550-0.700 EPS.

ZimVie Price Performance

ZimVie stock traded up $1.59 during mid-day trading on Thursday, hitting $16.97. The company’s stock had a trading volume of 950,507 shares, compared to its average volume of 340,342. The company has a quick ratio of 2.32, a current ratio of 2.78 and a debt-to-equity ratio of 1.26. The stock has a market capitalization of $461.92 million, a P/E ratio of -1.04 and a beta of 2.17. ZimVie has a twelve month low of $6.52 and a twelve month high of $20.91. The stock’s fifty day moving average price is $16.40 and its two-hundred day moving average price is $15.00.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on ZIMV shares. Needham & Company LLC reaffirmed a “hold” rating on shares of ZimVie in a report on Thursday. Barclays raised their price objective on shares of ZimVie from $13.00 to $16.00 and gave the company an “underweight” rating in a research note on Tuesday, March 5th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.